Utilizing Engineered E. Coli as an Asymmetric Reducing Biocatalyst Towards Serotonin Reuptake Inhibitors

Presenters/Authors

Richard J. Hammond, Armstrong Atlantic State UniversityFollow
Benjamin W. Poston, Armstrong Atlantic State UniversityFollow
Brent D. Feske, Georgia Southern UniversityFollow

Document Type

Presentation

Presentation Date

1-1-2007

Abstract or Description

This presentation was given at the ACS National Meeting.

Sponsorship/Conference/Institution

ACS National Meeting

Location

Boston, MA

Recommended Citation

Hammond, Richard J., Benjamin W. Poston, Brent D. Feske. 2007. "Utilizing Engineered E. Coli as an Asymmetric Reducing Biocatalyst Towards Serotonin Reuptake Inhibitors." Department of Biochemistry, Chemistry, and Physics Faculty & Staff Presentations. Presentation 238.
https://digitalcommons.georgiasouthern.edu/chem-facpres/238